Three risk factors for pulmonary metastasectomy in patients with hepatocellular carcinoma.

Akifumi NakamuraMinoru EsakiKazuo NakagawaKeisuke AsakuraYoji KishiSatoshi NaraKazuaki ShimadaShun-Ichi Watanabe

Published in: General thoracic and cardiovascular surgery (2019)

For patients who underwent pulmonary metastasectomy for hepatocellular carcinoma, median survival time was 25.0 months and decreased with three risk factors which included viral hepatitis, multiple number of pulmonary metastases, and the presence of other site recurrence before metastasectomy.

Keyphrases

pulmonary hypertension
risk factors
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
patient reported outcomes